Halozyme Therapeutic (NQ: HALO )
38.53
-0.24
(-0.62%)
Streaming Delayed Price
Updated: 12:05 PM EDT, Apr 30, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
9 Analysts Have This To Say About Halozyme Therapeutics
April 16, 2024
NASDAQ:HALO, a strong growth stock, setting up for a breakout.
February 21, 2024
The 3 Best Biotech Stocks to Buy in Q2 2024
March 29, 2024
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
Breaking Down Halozyme Therapeutics: 7 Analysts Share Their Views
February 21, 2024
Halozyme Therapeutics: Q4 Earnings Insights
February 20, 2024
Earnings Preview: Halozyme Therapeutics
February 19, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:HALO.
February 19, 2024
NASDAQ:HALO, an undervalued stock with good fundamentals.
February 09, 2024
NASDAQ:HALO, a strong growth stock, setting up for a breakout.
January 31, 2024
Earnings Scheduled For February 20, 2024
February 20, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|